Not All Fatty Liver Is Linked to Alcohol: The Silent Shift from Lifestyle Disease to Surgical Reality, Say Doctors

Dr Saswata Chatterjee, Gastroenterologist at CK Birla Hospitals, CMRI : Non-alcoholic fatty liver disease does not behave the way most people expect a serious condition to behave. There is no dramatic onset. A patient may carry excess fat in the liver for years without a single symptom, and the condition only surfaces when it has already moved past simple fat accumulation into inflammation, fibrosis, or worse. By the time a patient walks into a gastroenterologist’s clinic with complaints, the disease has often had a long, uninterrupted run.The clinical priority is to catch NAFLD before it reaches stages where the damage becomes difficult to reverse. Routine metabolic screening, abdominal ultrasound, and where indicated, tools like FibroScan can identify the problem early. At that stage, the condition responds well to lifestyle correction. Weight reduction of 5 to 10%, dietary changes, regular physical activity, and management of blood sugar and cholesterol can halt progression and, in many cases, reverse the damage entirely. The gastroenterologist’s job, in the context of fatty liver, is to make the surgeon unnecessary. But that only works if patients are screened before symptoms force them into a clinic.

Dr Ajay Mandal, Consultant GI and Hepatobiliary Surgeon at CK Birla Hospitals – CMRI: When fatty liver disease progresses without detection or intervention, a small subset of patients will reach a stage where surgery becomes unavoidable. This typically happens when long-standing cirrhosis leads to complications, or when hepatocellular carcinoma develops in a liver that has been silently deteriorating for years. These are not common outcomes, but they are real ones, and they tend to arrive in patients who had no idea their liver was compromised until the disease was advanced. Operating on a liver that has been through years of fat accumulation, inflammation, and fibrotic change is a different surgical challenge from operating on a healthy liver. The tissue is more fragile, the anatomy can be distorted, and the margin for error is narrower. This is where robotic-assisted surgery has made a measurable difference. The precision it offers in dissection and the ability to work in tight, compromised spaces allows surgeons to perform resections with less blood loss, smaller incisions, and a recovery timeline that is significantly shorter than what open surgery would require. It does not change the clinical indication for surgery. It changes how safely and effectively the surgery can be performed once that indication exists.